"The University of Kansas Cancer Center offers treatment in Lee’s Summit, Missouri. Patients have even greater access to treatment options and clinical trials available only at a National Cancer Institute-designated cancer center."

During the past decade, University of Kansas Cancer Center - Lee's Summit conducted 130 clinical trials. In the 10-year time frame, 130 clinical trials started and 56 clinical trials were completed, i.e. on average, 43.1% percent of trials that started reached the finish line to date. In the past 5 years, 60 clinical trials started and 43 clinical trials were completed. i.e. 71.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Kansas Cancer Center - Lee's Summit" #1 sponsor was "National Cancer Institute (NCI)" with 75 trials, followed by "SWOG Cancer Research Network" with 36 trials sponsored, "NRG Oncology" with 15 trials sponsored, "Alliance for Clinical Trials in Oncology" with 14 trials sponsored and "University of Kansas Medical Center" with 14 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Kansas Cancer Center - Lee's Summit" #1 collaborator was "National Cancer Institute (NCI)" with 77 trials as a collaborator, "NRG Oncology" with 17 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Novartis Pharmaceuticals" with 3 trials as a collaborator and "SWOG Cancer Research Network" with 3 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "University of Kansas Cancer Center - Lee's Summit" are "Breast Cancer" (11 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Prostate Cancer" (7 trials), "Stage IV Lung Cancer AJCC v8" (7 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials). Many other conditions were trialed in "University of Kansas Cancer Center - Lee's Summit" in a lesser frequency.

Most popular intervention types in "University of Kansas Cancer Center - Lee's Summit" are "Drug" (143 trials), "Other" (84 trials), "Biological" (62 trials), "Procedure" (48 trials) and "Radiation" (45 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (40 trials), "Quality-of-Life Assessment" (33 trials), "Biospecimen Collection" (29 trials), "Computed Tomography" (28 trials) and "Nivolumab" (22 trials). Other intervention names were less common.

The vast majority of trials in "University of Kansas Cancer Center - Lee's Summit" are 140 trials for "All" genders, 19 trials for "Female" genders and 18 trials for "Male" genders.

Currently, there are NaN active trials in "University of Kansas Cancer Center - Lee's Summit". undefined are not yet recruiting, 53 are recruiting, 88 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in University of Kansas Cancer Center - Lee's Summit, 4 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Kansas Cancer Center - Lee's Summit, 19 "Phase 1" clinical trials were conducted, 100 "Phase 2" clinical trials and 80 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".